Wms Partners, LLC Axsome Therapeutics, Inc. Transaction History

Wms Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$69.39 - $97.64 $693,900 - $976,400	-10,000 Reduced 19.72%	40,711 $3.25 Million
Q4 2023 Feb 12, 2024	SELL	$57.42 - $83.61 $1.72 Million - $2.51 Million	-30,000 Reduced 37.17%	50,711 $4.04 Million
Q3 2023 Nov 09, 2023	BUY	$69.25 - $82.21 $49,236 - $58,451	711 Added 0.89%	80,711 $5.64 Million
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $6.62 Million - $10.2 Million	-113,289 Reduced 58.61%	80,000 $5.75 Million
Q4 2022 Feb 07, 2023	SELL	$39.94 - $79.72 $28,397 - $56,680	-711 Reduced 0.37%	193,289 $14.9 Million
Q3 2022 Nov 08, 2022	SELL	$36.06 - $69.85 $1.75 Million - $3.39 Million	-48,500 Reduced 20.0%	194,000 $8.66 Million
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $230,250 - $325,200	-7,500 Reduced 3.0%	242,500 $9.16 Million
Q2 2020 Aug 12, 2020	BUY	$49.87 - $98.69 $12.5 Million - $24.7 Million	250,000 New	250,000 $20.6 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.77B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wms Partners, LLC with notifications on news.